74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical’s Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”).Proposed privatisation of Kangji Medical Holdings LimitedThe Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the ProposalThe Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidityHONG KONG, Aug 13, 2025 - (ACN Newswire via SeaPRwire.com) - Aug 12 2025, Kangji Medical Holdings Limited (“Kangji Medical” or the “Company”, Stock Code: 9997.HK) and Knight Bidco Limited (the “Offeror”) today jointly announced a privatisation proposal. The parties intend to implement the privatisation of the Company by way of a scheme of arrangement, with a view to enabling the Company to focus on long-term strategic decisions, such as longer-term business investment in R&D and operations enhancements.Upon completion of the Proposal, the Company will become a wholly-owned subsidiary of the Offeror, and the listing of the Shares will be withdrawn from the Stock Exchange.The Offeror is owned by a consortium comprising Mr. Zhong and Ms. Shentu (the Founders), the TPG Entities, NewQuest V and Al-Rayyan Holding.  Rationale for the ProposalDue to the long-term underperformance in the trading prices and trading liquidity of the Shares, the ability of the Company to raise funds from the equity market has been significantly limited. In addition, the Company has to incur administrative, compliance and other listing related costs and expenses for maintaining the listing status. Accordingly, there are limited benefits for the Company to maintain its listing status.In light of intensifying competition in domestic market and ongoing regulatory uncertainties, and in order to achieve sustainable growth, the Company's long-term strategy requires significant investment which could create short-term pressure on the Company’s financial performance. It is anticipated that additional resources need to be allocated to areas including sales and marketing, investment in research, development, and commercialisation, and the Company’s market expansion outside of China.Considering this, and the listing-related costs, there are limited benefits for Kangji Medical to maintain its listing status. In addition, the implementation of the Proposal will alleviate pressure on Kangji Medical’s short-term financial performance, which enables better focus on strategic objectives. It is anticipated that additional resources will need to be allocated for its future sustainable growth.Furthermore, the Proposal provides minority shareholders an attractive opportunity to realise compelling returns amid market volatility, industry and macro uncertainties, and the limited liquidity of the Shares.Knight Bidco Limited’s proposal offers a timely solution to Kangji Medical and its shareholders. Its proposal to privatise Kangji Medical will:(a) reduce Kangji Medical’s administrative, compliance and other listing related costs;(b) relieve Kangji Medical from the pressure associated with short-term performance metrics and enable Kangji Medical to focus on long-term strategic decisions (such as longer-term investment in R&D and operations enhancements which might incur short-term losses); and(c) present shareholders with certainty over their ability to monetise their interests in Kangji Medical at an attractive premium to the undisturbed share price.In summary, the Offeror believes that a take-private transaction is the strategic alternative that provides immediate and most compelling value for all shareholders, while also avoiding exposure to uncertain market conditions.Overview of the ProposalThe proposal sets out a Cancellation Price of HK$9.25 per share, valuing the company at approximately US$1.4 billion on an equity value basis.[1]The Offeror has indicated the Cancellation Price is final and will not be increased further.The Cancellation Price reflects:A 21.7% premium over the closing price on the Undisturbed Date (being 30 June, 2025).A 47.3% premium over the closing price of 360-trading day average price up to and including the Undisturbed Date.An 84.6% premium over the 52-week closing low (HK$5.01) up to and including the Undisturbed Date.A Cancellation Price above the highest closing price as quoted on the Stock Exchange since 2022 (HK$8.66).The Cancellation Price has taken into account, among other things, the recent and historical prices of the Shares traded on the Stock Exchange, publicly available financial information of the Company and with reference to other similar privatisation transactions in Hong Kong in recent years.The Proposal is subject to satisfaction of the Pre-Conditions by the Pre-Condition Long Stop Date (being 31 January, 2026) and the Conditions by the Long Stop Date (being 30 April, 2026). The Company will appoint an independent financial adviser (the “IFA”) to advise the committee of directors who are considered independent for the purposes of the Proposal (the “Independent Directors”) for the purposes of making a recommendation to shareholders in connection with the Proposal. Details of the Proposal including the Independent Directors’ final recommendation on the Proposal and the IFA’s advice will be included in the Scheme Document, expected to be dispatched to shareholders in due course.Scheme MeetingDetails of the Scheme Meeting to be convened will be contained in the Scheme Document which is expected to be dispatched to shareholders in due course.There are several pre-conditions and conditions as set out in the Joint Announcement, including regulatory approvals, shareholders approval and compliance with other legislative requirements.Irrevocable UndertakingAn Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal. Further details are available in the Joint Announcement.Trading in the Shares of the Company has been suspended on the Stock Exchange since 9:00 a.m. on 18 July, 2025, pending the release of this Announcement. The Company has applied to the Stock Exchange for the resumption of trading of Shares with effect from 9 a.m. on August 13, 2025.J.P. Morgan acted as the exclusive financial advisor to the Offeror.Kangji Medical Holdings LimitedKangji Medical is a medical device group founded in 2004 with headquarters at Hangzhou, Zhejiang Province, China. It was listed at the mainboard of the Stock Exchange of Hong Kong in June 2020 (Stock Code: 9997.HK). The Company specializes in the design, development, manufacture and sale of minimally invasive surgery instruments and accessories (“MISIA”). It strives for the mission of “providing physicians with high-quality products and services, and dedicating to improve people’s health”. The Company offers a comprehensive product portfolio to provide physicians and hospitals one-stop and tailored surgical solutions primarily for four major surgical specialties, including obstetrics and gynecology, general surgery, urology, and thoracic surgery. It is also committed to developing an internationally recognized minimally invasive surgery instruments and accessories platform with global coverage.About Knight Bidco LimitedEach of the Offeror, MidCo and TopCo is a newly incorporated company in the Cayman Islands with limited liability and an investment holding company set up solely for the purposes of implementing the Proposal. As at the date of the announcement, the Offeror is wholly owned by MidCo, which in turn is wholly owned by TopCo. As at the date of this announcement, TopCo is held by the Consortium Members, as to approximately 25.53% by Fortune Spring ZM, approximately 14.47% by Fortune Spring YG, approximately 24.38% by TPG Asia VII, approximately 5.01% by Keyhole, approximately 5.69% by Knight Success, approximately 4.56% by NewQuest V and approximately 20.36% by Al-Rayyan Holding. As at the date of this announcement, save as disclosed in the section headed “Shareholding Structure of the Company” in the Joint Announcement, none of TPG Asia VII, Keyhole, Knight Success, NewQuest V and Al-Rayyan Holding is a Shareholder.Kangji Medical is controlled by Mr. Zhong and his spouse Ms. Shentu who together hold 52.98% of the shares in Kangji Medical. Following the privatisation of Kangji Medical, Mr. Zhong and Ms. Shentu will remain the largest shareholders in the ultimate parent company of the Offeror, holding 40.00% of the shares in TopCo via Fortune Spring ZM and Fortune Spring YG. Further details are available in the Joint Announcement.Each of the Founder Entities is a business company incorporated in the British Virgin Islands.Knight Success is a newly incorporated company in Singapore with limited liability and an investment holding company. Keyhole is an exempted company incorporated in the Cayman Islands with limited liability and an investment holding company. TPG Asia VII is a company incorporated in Singapore with limited liability. Each of Knight Success and Keyhole is either wholly owned or controlled by TPG Asia VII, which is in turn controlled by TPG Asia GenPar VII Advisors, Inc. and ultimately controlled by TPG Inc., a publicly traded Delaware corporation (NASDAQ).TPG is a leading global alternative asset management firm founded in 1992 with more than US$269 billion of assets under management as of 30 June 2025. For many years, TPG has been investing in transformation, growth, and innovation and aims to build dynamic products and strategies for its investors while also instituting discipline and operational excellence across its investment strategies and performance of its portfolios.NewQuest V is a company incorporated in Singapore with limited liability and an investment holding company. NewQuest V is wholly owned by NewQuest Asia Fund V, L.P., which is in turn controlled by NewQuest Asia Fund V GP Ltd. and ultimately controlled by TPG Inc., a publicly traded Delaware corporation (NASDAQ).Established in 2011, NewQuest is one of Asia’s leading secondary private equity platforms with the most experienced secondary team in Asia across five offices. Since its founding, NewQuest has focused on working with GPs to create bespoke, tailored solutions to meet liquidity and other strategic needs of private asset owners and their stakeholders. Starting from a strategic partnership forged in 2018, NewQuest became wholly owned by TPG in January 2022.Al-Rayyan Holding is a limited liability company established in 2012 under the regulations of the Qatar Financial Centre Authority in the State of Qatar, and is a 100%-owned indirect subsidiary of QIA, the sovereign wealth fund of the State of Qatar. QIA was founded in 2005 to invest and manage the state reserve funds. QIA is among the largest and most active sovereign wealth funds globally. QIA invests across a wide range of asset classes and regions as well as in partnership with leading institutions around the world to build a global and diversified investment portfolio with a long-term outlook. As at the date of this announcement, Al-Rayyan Holding and its concert parties (other than those who are, or deemed to be, acting in concert with Al-Rayyan Holding solely in connection with the Consortium) are not interested in any Shares.For enquiries, please contact:Kangji Medical Holdings LimitedOfferorMedia contact: Wonderful Sky Financial Group LimitedAngie Li & Jason LaiTel: +852 6150 8598 / +852 9798 0715Email: po@wsfg.hkMedia contact: Brunswick GroupKatelin Stevenson & Tong Li+852 9875 3351 / +86 134 8872 6729TeamKnight@brunswickgroup.com[1] Based on  HK$9.25 Cancellation Price per share, 1,207,994,000 shares outstanding, and USD/HKD of 7.85All capitalized terms which are used in this press release but not otherwise defined herein shall have the meanings ascribed to them in the Joint Announcement dated 12 August, 2025. This press release should be read in conjunction with the Joint Announcement, a copy of which is available on https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201338.pdf. Copyright 2025 ACN Newswire via SeaPRwire.com.

74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

首程控股(0697.HK)抽取88位幸运观众现场观赛 深度参与世界人形机器人运动会

香港,2025年8月13日 - (亚太商讯 via SeaPRwire.com) - 备受全球科技界关注的世界人形机器人运动会将于8月14日在北京国家速滑馆正式拉开帷幕,这场持续至8月17日的科技盛宴,将成为展现全球人形机器人技术最高水平的重要窗口。作为全球首个以人形机器人为核心参赛主体的大型综合性赛事,本次运动会设置了极具看点的多元竞赛项目。来自世界各地的超百支顶尖机器人战队,将在跑步、足球、街舞、武术、工厂搬运、酒店服务等项目上进行比拼,全面展示人形机器人在不同领域的应用潜力。这背后不仅是技术的较量,更是对机器人适应复杂环境、完成精细任务能力的全方位检验,每一个项目的背后都凝聚着人工智能、机械工程等多学科的技术突破。一、首程控股多维度深度参与本届运动会中,首程控股扮演了资本推动者、场景验证者与生态运营者的三重角色。依托管理的北京机器人产业发展投资基金及多支产业基金,首程已系统投资布局数十家高成长机器人企业,覆盖从核心零部件到整机集成、从底层算法到场景应用的全产业链。此次亮相的被投企业包括:宇树科技(Unitree Robotics)、银河通用(Galbot)、星海图(Galaxea-AI)、松延动力(Noetix Robotics)、加速进化(Booster Robotics)、自变量机器人(X Square Robot)等,分别在足球、田径、格斗、舞蹈、场景赛等核心项目中担纲主力。二、首程机器人科技体验店打造沉浸式产业橱窗运动会期间,位于国家速滑馆内的首程机器人科技体验店同步开放,集中展示50余家企业近200款产品,涵盖智慧家居、教育、智能穿戴、娱乐休闲等多个场景。观众不仅可以近距离体验人形机器人、智能家电、AI娱乐设备等前沿产品,还可现场购买,实现"发布-测试-销售-服务"的消费闭环。这一举措与首程2025年启动的全球"机器人综合体验店"招募计划一脉相承,将为后续在融石广场等地开设的长期体验店积累场景与运营经验。首程控股董事会主席赵天旸表示,机器人市场规模未来将超越汽车行业,中国必将诞生百亿美元市值的机器人企业。而通过运动会这一"产业橱窗",首程不仅展示被投企业技术实力,更在真实环境中验证其商业化潜力,加速技术从"实验室走向市场"的进程。三、租赁公司保障赛事落地 为保障赛事前期训练与正式比赛,北京机器人租赁公司集中交付了100台赛事指定设备,包括82台加速进化足球赛本体、10台松延动力田径机器人和8台银河通用场景赛机器人。设备已全部进驻国家速滑馆,重点服务足球赛、田径赛及场景赛的训练需求,并由租赁公司与厂商技术团队联合驻场提供全流程技术支持,实现"即交付、即服务"的产业响应。观赛互动福利为感谢市场长期以来的支持,首程控股将通过抽签选出88位幸运观众亲临现场,共同见证这场全球顶尖科技的竞技舞台。报名注册截止日期:北京时间2025年8月14日上午9:00抽签时间:2025年8月14日下午3点前公布,受邀者将收到邮件或短信通知参与方式1.通过链接填写报名信息:https://www.wjx.cn/vm/mfW64yI.aspx#2.关注"首程控股"官方微信公众号,后台留言「机器人运动会」,根据弹出链接填写报名信息。 Copyright 2025 亚太商讯 via SeaPRwire.com.

康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景

康基医疗控股有限公司与Knight Bidco Limited今日联合宣布,拟通过协议安排("建议交易")对公司进行私有化。康基医疗控股有限公司私有化要约:每股9.25港元的注销价较股份于截至未受干扰日期(即2025年6月30日)之收盘价溢价约21.7%,较股份于截至未受干扰日期(包括该日)止360个交易日在联交所所报的平均收盘价溢价约47.3%,且超过了2022年以来于联交所录得之最高收盘价。本次私有化拟以协议安排方式实施,要约人及其一致行动人士合共持有公司74.75%之股份;已获得一家机构股东作出的不可撤销承诺,将投票支持该私有化方案。该方案为股东提供明确机会,使其能够于康基医疗控股有限公司之股份持续面临交易价格压力及流动性受限之际,变现其于公司之权益。香港,2025年8月13日 - (亚太商讯 via SeaPRwire.com) - 2025年8月12日,康基医疗控股有限公司("康基医疗"或"公司",股份代号:9997.HK)与KNIGHT BIDCO LIMITED"要约人"今日联合宣布,双方拟以协议安排的方式对公司进行私有化,以期公司能够专注于长期战略决策,包括研发长期投入及运营升级。待该方案完成后,公司将成为要约人的全资附属公司,而公司股份于联交所的上市地位将被撤销。要约人由以下成员组成的财团全资持有:钟先生与申屠女士(创始人)、TPG实体、NewQuest V基金及Al-Rayyan Holding。交易理据鉴于股票的交易价格持续承压且流动性长期不足,公司从股票市场筹集资金的能力受到严重限制。除此之外,本公司为维持上市地位须承担行政、合规及其他与上市相关之成本及开支,故维持上市地位之裨益有限。由于国内市场竞争加剧及持续之监管不确定性,为实现可持续增长,公司的长期策略需进行重大投资,此举可能对短期财务表现造成压力。预计需将额外资源分配至以下领域:销售与市场推广、研发及商业化投资,以及中国境外之市场扩张。鉴于维持上市地位的裨益有限,且涉及相关上市成本,康基医疗继续维持上市地位之必要性已显著降低。此外,该方案的实施将缓解公司短期财务表现所受压力,从而更专注于战略目标的推进。公司预期需要配置更多资源,以保障其未来可持续发展。此外,该方案为少数股东提供具吸引力的机会,使其能在市场波动、行业及宏观不确定性,以及股份流动性有限之情况下,实现可观回报。KNIGHT BIDCO LIMITED提出的私有化方案为康基医疗及其股东提供了及时有效的解决方案,提议将康基医疗私有化的方案将:(a) 降低康基医疗的行政、合规及其他上市相关成本;(b) 缓解康基医疗面临的短期业绩指标压力,使康基医疗能够专注于长远战略决策(例如可能导致短期亏损的长期研发投入及运营升级);以及(c) 为现有股东提供明确保障,使其能以显著高于未受干扰股价的溢价,实现于康基医疗的权益变现。综上所述,要约方认为私有化交易能为全体股东提供即时且最具吸引力价值的战略选择,同时可规避不确定市场环境带来的风险。交易方案概述本次私有化方案设定的股份注销价格为每股9.25港元,按股权价值计算对公司估值约为14亿美元[1]。要约方已明确表示,注销价格为最终定价且后续不会上调。该注销价格体现以下考量:较股份于未受干扰日期(即2025年6月30日)在联交所所报收盘价溢价约21.7%。较股份于截至未受干扰日期(包括该日)止360个交易日在联交所所报的平均收盘价溢价约47.3%。以及截至未受干扰日期(包括该日)止于联交所所报之股份价格的过去52周最低收盘价(5.01港币)溢价约84.6%。此外,在较长的过往期间内,注销价格超过了股份自2022年以来的最高收盘价(8.66港币)。本次注销价格的确定已综合考量下列因素(包括但不限于),股份于联交所的近期及历史交易价格,公司公开披露的财务资讯,及参照近年来香港市场类似私有化交易案例。该方案的实施受限于所有先决条件于2026年1月31日(先决条件最后截止日期)或之前达成,并在2026年4月30日(最后截止日)之前满足条件。公司将委任独立财务顾问("IFA")向为方案目的而设立的独立董事委员会("独立董事委员会")提供意见,以便就方案向股东作出推荐建议。方案的详情,包括独立董事委员会的最终推荐意见及独立财务顾问的意见函,将载入计划文件,并预期在切实可行的情况下尽快寄发给股东。协议安排会议协议安排会议的具体细节将载于计划文件,该文件预计将于适当时候寄发予股东。本次交易尚需满足《联合公告》所列的多项先决条件及条件,包括但不限于监管批准、股东批准及其他法定合规要求。不可撤销承诺本公司已获得一名机构股东作出的不可撤销承诺,将就该项提案投赞成票。详情请参阅《联合公告》。康基医疗已于2025年7月18日上午9时正起于联交所暂停买卖,以待刊发本公告。公司已向联交所申请股份自2025年8月13日上午9点起恢复买卖。摩根大通担任要约方独家财务顾问。关于康基医疗控股有限公司康基医疗控股有限公司创立于2004年,总部位于中国浙江省杭州市,于2020年6月在香港联合交易所主板上市,股票代码9997.HK。公司专注于设计、开发、生产和销售微创外科手术器械及配套耗材("MISIA"),秉持着"为医生提供优质产品和服务,致力于人类健康事业"为使命,通过丰富的产品组合为妇产科、普外科、泌尿外科和胸外科等临床科室的微创外科手术提供一站式解决方案,并致力于发展为一个立足中国,辐射全球的国际化微创外科手术器械及配套耗材平台。关于Knight Bidco Limited要约人、MidCo 及TopCo均为于开曼群岛新注册成立的有限公司及仅为实施该建议而成立的投资控股公司。于公告日期,要约人由MidCo全资拥有,而MidCo由TopCo全资拥有。于本公告日期,TopCo由财团成员持有,其中Fortune Spring ZM、Fortune Spring YG、TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding分别持有约25.53%、约14.47%、约24.38%、约5.01%、约5.69%、约4.56%及约20.36%。于本公告日期,除《联合公告》中"公司的股权架构"一节所披露外,TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding均非股东。康基医疗现由钟鸣先生及其配偶申屠女士共同控制,二人合计持有康基医疗52.98%股份。待私有化完成后,钟氏夫妇将通过Fortune Spring ZM与Fortune Spring YG继续持有要约方最终控股公司(TopCo)40.00%股权,并保持第一大股东地位。更多细节详见《联合公告》。各创始人实体均为在英属维尔京群岛注册成立的商业公司。Knight Success为一家于新加坡新注册成立的有限公司且为一家投资公司。Keyhole为一家于开曼群岛注册成立之获豁免有限公司及投资控股公司。TPG Asia VII为一家于新加坡注册成立的有限公司。Knight Success及Keyhole均由TPG Asia VII全资拥有或控制,而后者由TPG Asia GenPar VII Advisors, Inc.控制,并最终由纳斯达克上市的特拉华州公司TPG Inc.控制。TPG是一家全球领先的另类资产管理公司,成立于1992年,截至2025年6月30日年管理的资产超过2,690亿美元。多年来,TPG一直致力于投资变革、增长与创新,旨在为投资者构建多元化的产品与策略,同时借由贯彻纪律及卓越的营运管理,提升投资策略与投资组合的整体表现。NewQuest V为一家于新加坡注册成立的有限公司及投资控股公司。NewQuest V由NewQuest Asia Fund V, L.P.全资拥有,而后者由NewQuest Asia Fund V GP Ltd.控制,并最终由纳斯达克上市的特拉华州公司TPG Inc.控制。NewQuest成立于2011年,是亚洲领先的二级私募股权平台之一,拥有亚洲最有经验的二级团队,分布于五个办事处。自成立以来,NewQuest一直专注于与普通合伙人合作,创建定制的解决方案,以满足私募资产持有人及其利益相关者的流动性和其他战略需求。从2018年建立的战略合作伙伴关系开始,NewQuest2022年1月成为TPG的全资附属公司。Al-Rayyan Holding为一家根据卡塔尔金融中心管理局的规定于2012年在卡塔尔成立的有限责任公司,且为卡塔尔主权财富基金卡塔尔投资局全资拥有的间接附属公司。成立于2005年的卡塔尔投资局旨在投资和管理国家储备基金。卡塔尔投资局为全球最大、最活跃的主权财富基金之一。卡塔尔投资局投资于广泛的资产类别及地区,并与世界各地的领先机构合作,建立具有长期前景的全球化及多元化投资组合。于本公告日期,Al-Rayyan Holding及其一致行方(与Al-Rayyan Holding 单独或被视为与该财团一致行事的各方除外)均不持有任何股份。如有垂询,敬请联系:康基医疗控股有限公司要约人传媒联络:皓天财经集团有限公司Angie Li & Jason Lai电话:(+852) 6150 8598 / (+852) 9798 0715电邮:po@wsfg.hk传媒联络: 博然思维Kay Lau电话:+852 6021 7009Tong Li电话:+86 134 8872 6729电邮:TeamKnight@brunswickgroup.com[1] 以每股9.25港币的注销价格、1,207,994,000股流通股,以及7.85的美元兑港币汇率计算免责声明:本新闻稿中使用的所有未另行定义的大写术语,其含义均以2025年8月12日发布的《联合公告》中的释义为准。本新闻稿须与《联合公告》全文一并阅读,公告副本可在以下链接查阅。https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201339_c.pdf Copyright 2025 亚太商讯 via SeaPRwire.com.

Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan

HONG KONG, Aug 8, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R). NEFECON(R) is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression, irrespective of proteinuria levels.With this label update, the previous requirement in accelerated approval stage to submit full confirmatory trial analysis to demonstrate clinical benefit has been formally removed. Additionally, data demonstrating NEFECON(R)’s efficacy in delaying kidney function decline has been included in the approved product label. IgAN is highly prevalent among Asian populations, with a 56% higher risk of progression to end-stage renal disease compared to other groups and often progresses more rapidly.Taiwan region became the last region across all Everest’s territories to grant full approval for NEFECON(R), together with Mainland China, Singapore, Macao SAR, Hong Kong SAR and South Korea. This further demonstrates NEFECON(R)’s foundational first-line cornerstone treatment for IgAN patients."NEFECON(R) has received full approval in Taiwan, further validating its outstanding clinical value and offering physicians a more solid clinical foundation for treatment decisions.” Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines, said. “As the first and only fully approved etiological treatment for IgAN, NEFECON(R) has now achieved full approval across Asia. This milestone will benefit a broader patient population by enabling more individuals with IgAN to access this etiological treatment earlier, helping to slow disease progression and improve quality of life. We will continue to expand the accessibility and affordability of NEFECON(R) across Asia, aiming to benefit more IgAN patients and improve their quality of life."The approval is based on the global Phase 3 NefIgArd clinical trial, which showed that compared to placebo, it not only brought about a durable reduction in proteinuria and reduced the frequency of microscopic hematuria but also demonstrated clinically relevant and statistically significant treatment benefits in estimated glomerular filtration rate (eGFR), reducing the decline in kidney function by 50% over a period of 2 years, comprising 9 months of treatment and 15 months of observation, and potentially delaying the progression to dialysis or kidney transplantation by 12.8 years.Additionally, the complete 2-year data of the NefIgArd study further analyzed the potential differences in the response to NEFECON(R) treatment between Asians (n=83) and Caucasians (n=275). The results showed that compared to placebo, treatment with NEFECON(R) for 9 months in both Asians and Caucasians can significantly delay the decline of eGFR, protect kidney function, and bring about a sustained reduction in proteinuria and reduce the risk of microscopic hematuria.NEFECON(R) has been recommended by several authoritative treatment guidelines, including the “KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (Public Review Draft)”, and the "Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)". NEFECON(R) was included in China’s National Reimbursement Drug List (NRDL) in November 2024, and the supplemental application for the production expansion of NEFECON(R) has been officially approved by NMPA in August 2025.NEFECON(R) is currently the world’s first IgAN treatment to have received full approval from the National Medical Products Administration (NMPA) in China, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency(MHRA)in the United Kingdom , as well as in other Asian territories where Everest Medicines holds the rights, including Hong Kong SAR, Macao SAR, Taiwan region (China), Singapore, and South Korea. Copyright 2025 ACN Newswire via SeaPRwire.com.

Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips

HONG KONG, Aug 8, 2025 - (ACN Newswire via SeaPRwire.com) - Currently, advancements in artificial intelligence (AI) technology are driving the evolution of AI from iterative improvements in algorithms to significant breakthroughs in computational infrastructure. During this round of technological evolution, a massive demand for AI inference computing is emerging, setting new benchmarks for the architecture and cost-efficiency of computing power.Compared with general-purpose GPU architectures, NPU chips designed specifically for AI inference scenarios have become the foundation supporting the large-scale commercialization of AI industries due to the advantages such as high cost-effectiveness, energy efficiency and customization. These chips are gradually becoming one of the mainstream development directions for AI chips, accelerating the industry's transition from an era centered on GPUs for large model training to an era focused on NPUs for AI inference computing. In this race, the innovation capabilities at the foundational architecture level and extensive experience in large-scale application deployment are progressively contributing to a company’s overall competitiveness and sustainability.Among these players, Shenzhen Intellifusion Technologies Co., Ltd. (“Intellifusion”) is the first company to commercialize domestic high computing power AI inference chips in China. As a pioneer in NPU research and design, Intellifusion integrates multiple generations of architectural technical knowledge with mature commercialization experience to create high-performance, cost-effective and highly versatile inference chips. Intellifusion has achieved large-scale deployments across enterprise, consumer and industry-grade scenarios, establishing a leading position in China's AI inference chip-related products and services market in terms of revenue in 2024. On July 30, Intellifusion submitted its listing application to the Hong Kong Stock Exchange.Led by a “Hardcore” management team: providing strong traction for strategic implementationIn the deep tech sector of AI chips where technology, capital and talent concerntration converge, the management team serves not only as decision-maker for corporate strategy but also as "navigators" guiding Intellifusion through technological and industrial cycles. Intellifusion’s ability to gain a firm foothold in the highly complex and fiercely competitive AI inference chip market is inseparable from its core team, which boasts strategic foresight, technical prowess and hands-on industry experience.Dr. Chen Ning, founder, executive director and general manager of Intellifusion, is a worldwide rare expert with deep experience in semiconductor and possesses both overseas and domestic industry experience. Standing at the forefront of technology, Dr. Chen deeply understands the path from theoretical breakthroughs to product transformation, and not only possesses visionary technical foresight, but also demonstrates strong execution capability in industrialization and commercialization, which enable him to grasp Intellifusion's long-term strategic trajectory from the cutting edge of technological development with commercialization capability, and drive deep innovation along the "algorithm + chip" integration path, providing long-term traction for Intellifusion’s sustained growth.As one of the key pioneers in China's domestically-developed AI inference chips, Dr. Chen Ning has spearheaded the design and development of homegrown AI inference chips, achieving end-to-end innovation from algorithmic breakthroughs to chip-based implementation. He can rightly be considered one of the founding figures in the industrialization of China's AI inference chips. His recognition as the prominent individuals in innovation and entrepreneurship and outstanding role models at the 40th Anniversary of Shenzhen Special Economic Zone, and in July of this year, he was selected alongside entrepreneurs such as Xingxing Wang, founder of Unitree Robotics, Weiliang Chen, founder of MetaX, and Peng Zhang, CEO of Zhipu AI, as one of CCTV’s ‘AI Leaders of the Year’,.further solidifies his strategic leadership position in China's AI industry.Under the leadership of Dr. Chen Ning, Intellifusion has assembled a elite Research & Development (“R&D”) team with core members averaging over 25 years of experience in the AI industry. These veterans have long served at leading domestic technology companies, covering the entire critical technology chain from chip architecture design to algorithm development and optimization. As of the Latest Practicable Date, Intellifusion boasts 489 R&D personnel, including more than 50 engineers with over a decade of chip design experience and multiple national-level leading technical experts. This composition has established a synergistic system for chip design and algorithm development guided by seasoned industry specialists, providing robust support for rapid product innovations and continuous technological breakthroughs."Algorithm + chip" integrated strategy builds high technological barriersUnlike traditional "algorithm companies" or "chip companies" that focus on singular breakthroughs, Intellifusion has consistently adhered to the advanced concept of co-designing algorithms and chips since its inception. This approach has forged an integrated software-hardware technical capability that creates a self-reinforcing virtuous cycle, where insights from real-world deployment continuously refine algorithms, algorithmic innovations drive chip architecture upgrades, and enhanced chip performance unlocks new application scenarios. This creates a compounding flywheel effect, progressively elevating R&D efficiency and commercial scalability.At the foundational technology level, Intellifusion has established its proprietary "IFIC" platform through its algorithm-to-silicon integration capability. This end-to-end system encompasses the entire AI inference chip R&D process: algorithm analysis - instruction set definition - chip architecture design - toolchain optimization. This enables Intellifusion to develop successive generations of NPUs and AI inference chips, ensuring optimal efficiency and scenario-specific adaptability.For architectural design, Intellifusion launched “AI Computing Blocks” by employing fully home-grown advanced domestic manufacturing processes, secure supply chain with advanced semiconductor processes, featuring standardized compute units that can be stacked like building blocks to flexibly configure chips with variable computing power and enable multi-chip interconnect for scalable systems, realizing single tape-out enables multiple packaging variants, efficiently producing chips of diverse specifications while balancing flexibility and cost. To address the data transmission bottleneck of traditional computer chips, Intellifusion has pioneered an innovative Near-memory Hyper-converged Architecture, which realizes vertical integration by seamlessly combining memory and computing units in a stacked configuration, enabling direct data flow through the 3D structure, eliminating bandwidth limitations of traditional packaging interconnections, achieving on-chip bandwidth and sub-nanosecond latency, dramatically lowering the energy consumption of data transportation, and perfectly adapting to the needs of real-time loading of large-model parameters.In the chip domain, Intellifusion has developed its DeepEdge Series of inference chips based on the "IFIC" Infrastructure, utilizing the innovative " AI Computing Blocks" Architecture. Currently, DeepEdge10 Series covers a wide range from 8T to 128T of computing power per chip and supports Transformer-based models for efficient AI inference, which can realize balanced performance & efficiency, low power consumption, and flexible deployment.In terms of technology update, Intellifusion has completed development of its 4th-generation NPU and is now advancing R&D for the next-generation high-performance NPU, Nova 500.This integrated R&D system centered on "algorithms + chips" enables Intellifusion to not only ensure leading-edge performance and rapid iteration in chip design but also continuously strengthen its technological moat through product adaptability, deployment scalability, and ecosystem expansion. Notably, Intellifusion has been awarded the highest award for intelligent science and technology in China. - the "Wu Wenjun AI Science & Technology Award " - three times, making it the only company in China to have won top prizes in all three categories: algorithms, chips, and applications. This recognition underscores its end-to-end innovation capability, from core technology development to industrial implementation.Riding the Global Inference Wave: Securing Long-Term Value in AI ChipsAs the proportion of inference computing in the total lifecycle cost of large models continues to rise, surging application demand will dramatically expand the scale of inference computing needs, creating a historic opportunity for the AI industry. According to the CIC Report, the market size of AI inference chip-related products and services industry in China is expected to reach RMB1,383.0 billion by 2029, at a CAGR of 53.4% from 2024 to 2029. In particular, the NPU-powered market size is projected to climb to RMB395.4 billion by 2029, at a CAGR of 72.3% from 2024 to 2029, significantly outpacing the overall market.Under the guideline of the advanced algorithm-to-silicon chip design methodology, Intellifusion, a pioneer in the high-potential market, has established an integrated software-hardware technical capability that creates a self-reinforcing virtuous cycle. Its products and services have been validated across multiple critical application scenarios, positioning Intellifusion as an industry frontrunner. According to the CIC Report, Intellifusion is a global top-three leader in full-scenario AI inference chip-related products and services in China, based on the relevant revenue in 2024. Intellifusion is also a top-two provider of NPU-powered AI inference chip-related products and services in China, based on the relevant revenue in 2024.Leveraging its IFIC Infrastructure, R&D capabilities in AI inference chips, and deep market insight, Intellifusion can respond quickly to changes in industrial demands and grasp the opportunity in the upcoming boom in AI inference chip-related products and services industry. Supported by policy tailwinds, growing application maturity, and semiconductor supply chain localization trends, Intellifusion is strategically positioned to capitalize on China’s golden window for domestic AI chips, emerging as both a key beneficiary and driver in the global recomposition of AI compute power.In summary, Intellifusion has not only achieved full autonomy from self-developed architectures to ecosystem development but also made breakthroughs across market expansion, technological innovation, and product commercialization, establishing a difficult-to-replicate end-to-end advantage. Should its Hong Kong IPO proceed smoothly, at the time of listing, Intellifusion could potentially become China’s first and only artificial intelligence company with a dual A+H listing (Shanghai + Hong Kong). This milestone would fully unlock cross-border M&A opportunities, allowing Intellifusion to aggregate global resources, attract top-tier AI talent worldwide, and further solidify its leadership in China’s AI industry, particularly in the inference chip segment. Copyright 2025 ACN Newswire via SeaPRwire.com.

MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth

HONG KONG, Aug 12, 2025 - (ACN Newswire via SeaPRwire.com) - MMG Limited (“MMG”, stock code: 1208) has today announced its Interim Results with a net profit after tax of US$566.3 million. This represents more than a 600 per cent increase compared to a net profit after tax of US$79.5 million in the first half of 2024.The strong profit growth was primarily driven by increased copper production across all three copper mines, higher market prices for copper, gold, silver and zinc, as well as reduced unit costs at Las Bambas driven by higher copper production.“Over the first half of the year, our business delivered an outstanding operational and financial performance,” said Ivo Zhao, MMG’s CEO. “This result reflects the strength of our portfolio, the capability of our people, and the disciplined execution of our strategy.”Importantly, MMG’s safety performance improved with a total recordable injury frequency (TRIF) of 1.81 per million hours worked in the first half of 2025, an improvement compared to the full-year 2024 TRIF of 2.06. The significant events with energy exchange frequency (SEEEF) for the first half of 2025 remained consistent with the 2024 figure at 0.78 per million hours worked.Operationally, MMG achieved impressive copper sales and significantly improved production across all three of its copper assets, including a strong performance from Las Bambas and the ramp-up at Khoemacau and Kinsevere. Its Australian operations also maintained solid zinc production, despite navigating challenges including weather impacts, equipment reliability and lower grades due to mining sequence.Highlights include:Record first-half results for both EBITDA and EBIT, with EBITDA at US$1,539.9 million, representing a 98 per cent increase compared to the first half of 2024, and EBIT totalling US$1,058.8 million, an increase of 240 per cent over the same period.Net profit after tax was US$566.3 million, including a profit of US$340.0 million attributable to equity holders of the company.A 130 per cent increase in net cash flow from operations, totalling US$1,185.0 million, compared to the first half of 2024. This performance was mainly driven by increased copper sales and higher commodity prices.Balance sheet improvements, with record lows - since the acquisition of Las Bambas - in both net debt and gearing ratio. The Company’s net debt declined by US$903.3 million since the end of 2024, attributed to robust operational cash flow and the early repayment of US$500 million in Khoemacau Joint Venture Group borrowings. Gearing reduced from 41 per cent to 33 per cent over the first half of 2025.Record high total payable copper sales since 2018, reaching 237,651 tonnes in the first half of 2025.Las Bambas produced 210,637 tonnes of copper in copper concentrate in the first half of 2025, marking a 67 per cent increase compared to the same period in 2024. EBITDA reached a record high of US$1,310.5 million, representing a 122 per cent increase compared to the first half of 2024.“MMG’s balance sheet is in great shape – its strongest in 10 years - with debt reduction driven by higher profits and cash generation,” continued Mr Zhao. “Our ambition to become a top 10 global copper producer is within reach and we are well-positioned to achieve this through operational excellence, disciplined capital allocation, and a continued commitment to responsible mining.”Guidance for the year remains unchanged with total production aiming for a high end of 522,000 tonnes of copper and 240,000 tonnes of zinc. Las Bambas is expected to produce up to 400,000 tonnes of copper this year, assuming stable operating conditions and limited external disruptions. MMG is focussed on delivering its cost targets, with Las Bambas and Rosebery favourably adjusting their C1 cost range to reflect improved by-product credits and strong market conditions.The company is working to complete the recent Nickel Brazil acquisition and is confident in the long-term portfolio and growth contribution. MMG remains committed to supporting community development, strong local economies and employment and supplying the critical minerals the world needs for a sustainable future.Read the 2025 Interim Results announcement, watch a short CEO message and download company photos.About MMG Founded in 2009, MMG’s vision is to create a leading international mining company for a low carbon future. The company is headquartered in Melbourne, Australia and Beijing, China and listed on the Hong Kong Stock Exchange (HKEX1208). MMG’s portfolio supports copper, zinc and cobalt production, with soon to be nickel – products that are critical to achieving global decarbonisation and electrification targets. With operations in Australia, Botswana, the Democratic Republic of Congo and Latin America. More info here.  Copyright 2025 ACN Newswire via SeaPRwire.com.

Formerra Becomes North American Distributor for Syensqo PVDF

ROMEOVILLE, IL, Aug 12, 2025 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, has signed an agreement with Syensqo to distribute its Solef® Polyvinylidene Fluoride (PVDF) materials in North America. The agreement expands access to this critical material known for its combination of chemical resistance and flexibility. Solef® PVDF joins a growing list of high-performance materials in Formerra's portfolio designed to advance product development and innovation."With this new agreement, Formerra will be able to support customers across multiple markets with the materials they need to meet demanding application requirements," said Bob Long, Business Development Manager at Formerra. "In addition, this reinforces our commitment to delivering unmatched access, application support, and advanced materials for customers navigating complex performance and regulatory challenges."PVDF is positioned near the top of the performance pyramid for its outstanding chemical and heat resistance. Its inherent flexibility further enhances its suitability for demanding applications in chemical processing, healthcare, and automotive industries. Key properties* include:Heat resistance: Continuous use temperatures up to 150 degrees C (302 degrees F), bursting pressures of up to 139 bar (2,017 psi) at room temperatureChemical purity: Ultra-pure water resistivity, meeting SEMI F-57 specifications for the semiconductor industryBalance of strength and flexibility: Tensile yield strength up to 55 MPa (8,000 psi) with elongation at break up to 100%"We chose Formerra as our distribution partner for Solef® PVDF in North America because of their technical and commercial reach," said Rose Catherin, Sales Director Americas, Channel partners, Distribution and Digital Sales at Syensqo Specialty Polymers. "Their commitment to excellence and long-standing presence in critical markets make them an ideal fit to help expand the availability and use of Solef® PVDF."*As measured by TDSCaption: Formerra Becomes North American Distributor for Syensqo Solef®PVDF.Key Details:Formerra is an authorized distributor of Solef® PVDF from Syensqo in North America.The agreement includes support for high-performance applications across a broad spectrum of industries.PVDF offers excellent chemical resistance, thermal stability, and flexibility.Formerra provides technical guidance and supply chain expertise to support material selection and application development.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2025 ACN Newswire via SeaPRwire.com.

GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row

WESTLAKE, OH, Aug 12, 2025 - (ACN Newswire via SeaPRwire.com) - GEON® Performance Solutions, a global leader in the formulation, development and manufacture of performance polymer solutions, announced today that it received Great Place To Work® (GPTW) certifications for its USA, Canada, Mexico and China locations. Since partnering with GPTW in 2021, GEON's cultural and sustainability vision is to achieve this recognition each year.GPTW Certified GEON is Great Place to Work-Certified in the US, Canada, Mexico and China.GPTW asks employees to quantify and benchmark their experience, workplace culture and leadership behaviors which are proven to deliver market-leading revenue, employee retention and increased innovation."We are thrilled to receive Great Place To Work recognition in all four countries in which we operate for two consecutive years. Great Place To Work companies are evaluated against top employers globally, so this is a testament that our journey to cultural excellence is on the right track," said GEON Chief Executive Officer Tracy Garrison. "We believe leaders in the marketplace must also be leaders in the workplace. To do this, we nurture a positive work culture everywhere we operate while striving to grow in areas that still need improvement."GEON received a 79 percent engagement rating which exceeds the typical company by over 20 percent. GEON's score improved year-over-year in the U.S., Canada and China and held steady in Mexico. The U.S. survey included the full scope of GEON employees, including employees from Foster, LLC which GEON acquired in January of 2025.According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified™ great workplace. Additionally, employees at Certified workplaces are 93 percent more likely to look forward to coming to work and are twice as likely to be paid fairly and have a fair chance at promotion."Like the data show, achieving GPTW certification is not only a reflection of our culture, but it directly impacts our ability to retain good people who are excited to come to work each day," said GEON Chief Human Resources Officer Jerome Beguerie. "This has a direct impact on our customers and their experience with us."About GEON Performance SolutionsGEON® Performance Solutions is a leading innovator in the development of polymer compounding solutions for a broad range of markets including building & infrastructure, consumer, industrial, transportation, and power & communications. With the acquisition of Foster, LLC, GEON has enhanced participation in the high-growth healthcare and medical device industry and builds on a portfolio of highly adaptable vinyl, polyolefin and engineered resin technologies as well as a full-service contract manufacturing business. GEON has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. GEON is a portfolio company of SK Capital Partners.About SK CapitalSK Capital is a transformational private investment firm with a disciplined focus on the specialty materials, ingredients, and life sciences sectors. The firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital currently has approximately $10 billion in assets under management as of December 31, 2024. For more information, please visit www.skcapitalpartners.com.Contact InformationRenita AndersonVice President, Marketing & Business Developmentrenita.anderson@geon.com678-772-8953SOURCE: GEON Performance Solutions Copyright 2025 ACN Newswire via SeaPRwire.com.

China Lilang Announces 2025 Interim Results

HONG KONG, Aug 12, 2025 - (ACN Newswire via SeaPRwire.com) - China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its interim results for the six months ended 30 June 2025.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang, said: “In the first half of 2025, international trade environment became increasingly harsh and complex. During the period, consumer spending in the mainland gradually recovered, but consumers remained cautious about spending on non-essential goods. China Lilang prides a well-differentiated brand matrix that has enabled it to penetrate and have a strong foothold in the menswear market. It appealed to its target customer base through precise product positioning and channel strategies, and launched a number of ‘LILANZ’ and ‘LESS IS MORE’ brand products to meet the needs of the consumer market. In addition, the Group actively deployed omni-channel marketing to enhance the popularity of the Lilang brands and improve the efficiency of online and offline sales channels to boost overall sales and operational competence.”For the six months ended 30 June 2025, the Group’s revenue increased by 7.9% to RMB1,727 million. Among this, revenue of the smart causal collection and other collections urged 31.8%, mainly driven by strong performance in in-store sales of the smart casual collection and new retail business. The core collection recorded a slight decrease of 0.2%, primarily due to one-off revenue deduction resulting from the promotion of DTC business model in Shandong Province and Chongqing City.Gross profit margin increased by 0.2 percentage points year-on-year to 50.2%, mainly due to the increase in average unit price as a result of higher proportion of the direct-to-retail operation in sales revenue. Profit attributable to equity shareholders for the period was RMB242.5 million (2024 Interim: RMB280.1 million). Profit margin attributable to equity shareholders was 14.0%. Earnings per share were RMB20.2 cents.During the period, the Group maintained a healthy financial position with sufficient cash flow. The Board of Directors has recommended payment of an interim dividend of HK11 cents (2024 Interim: HK13 cents) per ordinary share and a special interim dividend of HK5 cents (2024 Interim: HK5 cents) per ordinary share, thereby maintaining a stable payout ratio.The Group diligently advanced its strategic transformation during the period, plus continued to implement its “Multi-brands and Internationalization” development strategy to expand business. The core collection “LILANZ” has continued to consolidate its competitive advantage in the traditional menswear market and successfully amplified its brand awareness and market share. The repurchase and transformation of distribution and agency rights in North-Eastern China and Jiangsu Province were completed last year. During the period, the Group has repurchased the operating rights from distributors in the entire Shandong province and Chongqing city and adopted the DTC model.  The "LESS IS MORE" smart casual collection that targets younger consumers continued to operate in a fully direct-to-retail mode. The newly opened stores of the smart casual collection were mainly in South-Western China and Central and Southern China. As at 30 June 2025, there were 2,443 stores for the core collection and 331 stores for the smart casual collection.During the period, the Group continued to optimize its sales channels, opening new stores in shopping malls and outlet stores in prime locations as planned. By incorporating tech-savvy visual aesthetics and youthful, fashionable layouts, the Group has brought the brand’s“Simplicity but not Simple” philosophy to life, thereby enhancing its brand image and driving sales. As at June 30, 2025, the number of stores located in shopping malls rose to 957 (31 December 2024: 933), the store count of outlet stores increased to 121 (31 December 2024: 103), with a total of 2,774 retail stores.The Group completed strategic transformation of its new retail business, upgrading it from an inventory clearance channel into a major new product sales platform, which reported a remarkable 24.6% increase in revenue for the period. While continuing to strengthen its presence on established sales platforms like Tmall, JD.com and TikTok, the Group has also expanded into emerging channels such as Pinduoduo, Wechat Channels and Poizon, creating diversified online sales network all together. It has kept enhancing its e-commerce strategy and leveraged social media platforms such as Xiaohongshu and Weibo to keep releasing high-quality content. This approach has deepened its emotional connection with consumers and presented it with new business opportunities.In terms of“Multi-brands and Internationalization” development strategy, the business of “MUNSINGWEAR” was successfully handed over to the Group in the first half of the year. The Group plans to open its first batch of physical stores in the second half of the year. The Group has opened its first store in Malaysia, which started trial operation in May, marking a significant step in overseas expansion.For the research, development and innovation and brand marketing, the Group is committed to achieving breakthroughs in fabrics, craftsmanship and technologies by pursuing proprietary research and development across its industrial chain, with the goal of enhancing the brand's core competitive advantages. During the period, the Group’s original durable white non-iron shirts, “Water Repellent Down 3.0” and the wash-resistant polo shirts have obtained multiple certifications for their anti-wrinkle, quick-drying, and wash-resistant features, successfully driving sales growth. To step up brand transformation aiming at youth consumers, the Group has harnessed celebrity influence, collaborated with cultural IPs, and employed immersive marketing tactics to engage consumers across various age groups and city tiers.Looking ahead to the second half of 2025, the development of domestic consumer market continues to be challenging. As an industry leader, China Lilang will press on with applying its strengths, following shifts in the consumer market and technological advancement, to promote transformation and to enhance brand influence, achieving sustainable sales and profit growth.In the second half year, the Group will continue to push forward with transformation. It will continue to capitalize on the operational advantages of the DTC model in North- Eastern China, Jiangsu Province, Shandong Province and Chongqing City to achieve healthy expansion, tailoring implementation taking into account the specific conditions of each market to further achieve optimal operational performance. For the smart casual collection, which is operated entirely in the direct-to-retail mode, will have its development foundation strengthened to help maintain its strong development momentum. The Group expects the DTC model to unleash its potential further in the second half year and contribute to sales growth.On the other hand, the Group will continue to leverage the advantages of its sales channel reform, focusing on opening stores in prime locations in premium shopping malls in provincial capitals and prefecture-level cities, and closing the underperforming stores to achieve better overall store performance. At the same time, the Group will prudently expand the layout of outlet stores and increase the number of stores to speed up inventory clearance. The Group aims to achieve a net increase of 50-100 stores in 2025.To achieve both the online and offline development, the Group will accelerate its new retails business by leveraging various platforms to engage young customer groups and strengthen brand market penetration. By increasing brand exposure through multi-dimensional initiatives, the Group aims to increase online sales of new products, expecting a rise to 80% of total e-commerce sales. It will work on optimizing the respond time of its supply chain to meet customers’ needs, via including continuously upgrading its the smart logistics center.With a solid domestic foundation, the Group is confident of accelerating implementation of its “Multi-brands and Internationalization” development strategy. As a key project of its multi-brand strategy, "MUNSINGWEAR" will continue to focus on product development in the second half year to meet the needs of the new middle class for personalized, functional and sustainable fashion. For its overseas business, the Group will open more stores in Malaysia in the second half year to better tap the Malaysian market, as well as actively deploy plans to expand business coverage to other Southeast Asian markets. Furthermore, the Group will promote its brand popularity through collaboration with IPs, as well as enhancing interaction with consumers through precise social media marketing and membership programs to foster customer loyalty and capture bigger market share.Mr. Wang Dong Xing, Chairman of China Lilang, concluded: “While China's consumer market remains challenging, the Group maintains cautious optimism toward the retail sector given the government's implementation of multiple consumption-stimulus measures. The ‘LILANZ’ core collection and the ‘LESS IS MORE’ smart casual collection have both undergone innovative transformation, emerging with clearer positioning. This will enable the Group to enhance precision and efficiency in product development, design, marketing promotion and sales, and ultimately drive the long-term growth. On the other hand, as a steadfast practitioner of sustainable development, the Group has deeply embedded ESG principles into its corporate strategy, consistently driving green innovation and social shared value. During the period, we issued our first independently compiled ESG report titled "Creat a Better Life Together" and formally established an ESG Management Committee, integrating ESG governance into strategic planning and core values – demonstrating our commitment to long-term value creation. Notably, the Group achieved an MSCI ESG rating upgrade to BB, ranking among China's top menswear industry peers. Looking ahead, the Group will continue to reinforce its leadership in the domestic menswear sector and strive to achieve sustainable growth through implementing flexible marketing strategy and continuous innovation, to the ultimate end of generating greater value for shareholders, its employees and customers."About China LilangChina Lilang is one of the leading PRC menswear enterprises. As an integrated fashion enterprise, the Group designs, sources and manufactures high-quality business and casual apparel for men and sells under brands of 'LILANZ' and 'LESS IS MORE' across an extensive distribution network, mainly covering 31 provinces, autonomous regions and municipalities in the PRC. Copyright 2025 ACN Newswire via SeaPRwire.com.

Shoucheng Joins World Humanoid Robot Games – 88 Spectators Invited

HONG KONG, Aug 13, 2025 - (ACN Newswire via SeaPRwire.com) - The highly anticipated World Humanoid Robot Games will officially open on 14 August at the Beijing National Speed Skating Oval and run through 17 August. This four-day technological extravaganza will serve as a premier showcase for the world’s most advanced humanoid robot technologies.As the world’s first large-scale comprehensive competition featuring humanoid robots as the main participants, the Games will include diverse and highly anticipated events such as running, football, street dance, martial arts, factory logistics, and hotel services. Over 100 top-tier robotics teams from around the globe will compete, fully demonstrating the application potential of humanoid robots across multiple domains. Beyond a contest of technology, the Games will be a comprehensive test of robots’ adaptability to complex environments and their ability to perform precision tasks, representing breakthroughs across AI, mechanical engineering, and other disciplines.1. Multi-Dimensional Involvement of Shoucheng HoldingsIn this year’s Games, Shoucheng Holdings acts as a capital enabler, scenario validator, and ecosystem operator. Through the management of the Beijing Robotics Industry Development Investment Fund and other industrial funds, Shoucheng has systematically invested in dozens of high-growth robotics companies, covering the entire value chain from core components to system integration, from fundamental algorithms to scenario applications. Its portfolio companies participating in the Games include Unitree Robotics, Galbot, Galaxea-AI, Noetix Robotics, Booster Robotics, and X Square Robot, each taking a leading role in core events such as football, track-and-field, combat, dance, and scenario competitions.2. Shoucheng Robotics Technology Experience Store – An Immersive Industry ShowcaseDuring the Games, the Shoucheng Robotics Technology Experience Store located inside the National Speed Skating Oval will be open to the public, displaying nearly 200 products from over 50 companies. These exhibits span smart home, education, wearable tech, and entertainment sectors. Visitors can experience cutting-edge products such as humanoid robots, smart appliances, and AI entertainment devices up close, and make on-site purchases – completing a “launch–test–sales–service” consumer loop. This initiative aligns with Shoucheng’s global “Robotics Comprehensive Experience Store” recruitment program launched in 2025, and will provide valuable operational insights for permanent experience stores planned at locations such as Rongshi Plaza.Chairman Zhao Tianyang stated that the robotics market will eventually surpass the automotive industry in scale, and that China will see the emergence of robotics companies valued at tens of billions of US dollars. Through the Games as an “industry showcase”, Shoucheng is not only presenting the technological strengths of its portfolio companies, but also validating their commercial potential in real-world environments – accelerating the journey from “lab to market.”3. Leasing Company Ensures Event DeliveryTo support training and official competitions, Beijing Robotics Leasing Company has delivered 100 designated competition robots, including 82 Booster Robotics football units, 10 Noetix Robotics track-and-field robots, and 8 Galaxea-AI robots for scenario events. All equipment has been deployed at the National Speed Skating Oval, serving training needs for football, track-and-field, and scenario competitions. The leasing company, together with manufacturer technical teams, has established an on-site service team to provide end-to-end technical support, achieving “immediate delivery, immediate service” responsiveness.Spectator EngagementTo thank its long-term supporters, Shoucheng Holdings will draw 88 lucky spectators to attend the Games in person and witness this world-class robotics competition.- Registration deadline: 14 August 2025, 9:00 a.m. (Beijing time)- Draw announcement: Before 3:00 p.m. on 14 August 2025 (Beijing time), with invitations sent via email or SMSParticipation methods:1.Fill out the registration form via: https://www.wjx.cn/vm/mfW64yI.aspx#2.Follow the official WeChat account 'Shoucheng Holdings', leave the message 'Robot Games', and complete the form via the link provided. Copyright 2025 ACN Newswire via SeaPRwire.com.

T-RIZE Group Lists $RIZE Token on Revolut App, Expanding Global Access to Tokenized Real-World Assets

New York, NY – August 13, 2025 – (SeaPRwire) – T-RIZE Group, a Global fintech company specializing in institutional-grade tokenization, has officially listed its native utility token, $RIZE, on the Revolut App. The listing brings $RIZE to one of the world’s most widely adopted financial platforms, expanding secure and regulated access to tokenized real-world assets (RWAs) for both retail and institutional participants. Following its Tier 1 exchange debut on Kraken, $RIZE’s listing on Revolut strengthens its presence across trusted global trading venues. The token provides access to assets onboarded through the T-RIZE platform and deployed across EVM-compatible chains like Base and institutional-grade networks such as the Canton Network. This multi-chain architecture enables secure, compliant, and scalable asset distribution across jurisdictions. The Utility of the $RIZE Token The $RIZE token serves as the entry point to the T-RIZE ecosystem. Asset owners use it to access and pay for tokenization services and distribution channels. Investors leverage it to participate in vetted offerings, while holders contribute to decentralized governance. A dedicated treasury – holding 30% of the total supply – supports proposal funding and ecosystem initiatives. Fully integrated across payment, access, and governance layers, $RIZE is foundational to how tokenized assets are issued and managed through the T-RIZE infrastructure. Accelerating Reach Through Revolut With over 60 million users and 1 billion+ monthly transactions, Revolut is one of the most trusted fintech platforms globally. Through Revolut’s crypto offerings, $RIZE is now accessible through the Revolut App, a streamlined gateway to 300+ exclusive tokens, with crypto payments and staking functionality. This listing expands $RIZE’s reach across both emerging digital users and institutional-aligned participants – anchored in Revolut’s regulatory track record and robust infrastructure. From Vision to Execution: A $2B+ Pipeline in Motion T-RIZE has moved rapidly from platform launch to commercial execution. Over $23 million in tokenized RWAs are already live, representing the first phase of a $300 million, 956-unit real estate tokenization agreement. The pipeline significantly exceeds $2 billion in signed MOUs and onboarding agreements. It spans new construction, tokenized equity, and structured financial products – driven by growing demand for a compliant, scalable tokenization solution. “The listing of $RIZE on Revolut is a strong signal of institutional-grade readiness,” said Madani Boukalba, CEO of T-RIZE Group. “It broadens global access to the token at the core of our infrastructure – designed to power secure, compliant, and scalable tokenization. This milestone reflects the trust built with partners and platforms, and the execution momentum behind our broader ecosystem strategy.” Institutional Infrastructure Supporting the Ecosystem T-RIZE’s growth is supported by a deep network of institutional-grade partners: Kraken – Tier 1 exchange where $RIZE launched via the Reef Program Wintermute – Market-making partner ensuring strong liquidity across platforms Chainlink – Oracle integration through CCIP, Proof of Reserve, Process, and Origin Fireblocks & DFNS – Secure custody and wallet infrastructure Canton Network – A privacy-first blockchain where T-RIZE operates as a validator and RWA issuer; the network secures over $4T in assets and processes $2T+ in monthly institutional transactions Looking Ahead With compliant infrastructure deployed and global network integrations in place, T-RIZE is preparing to launch additional tokenized offerings and ecosystem features. New listings and new product offerings such as financial structured products, are already in development, supporting the next phase of tokenized RWA adoption at institutional scale. Together, these building blocks position T-RIZE as a core infrastructure layer powering the next era of real-world asset finance. About Revolut Revolut is a global fintech and licensed European bank, helping people get more from their money. In 2015, Revolut launched in the UK offering money transfer and exchange. Today, more than 60 million customers around the world use dozens of Revolutʼs innovative products to make more than a billion transactions a month. Across our personal and business accounts – we give customers more control over their finances and connect people seamlessly across the world. www.revolut.com About T-RIZE Group Founded in 2022, T-RIZE is an institutional tokenization platform onboarding a multi-billion-dollar pipeline of real estate, structured financial products, and AI Energy Offset Reserve Notes. The T-RIZE platform transforms these assets into programmable digital instruments that unlock liquidity, lower capital costs, and enhance underwriting and risk modelling while protecting sensitive data through privacy-preserving AI. At its core, the RIZE token powers tokenization services, connects institutions to vetted investments and AI-driven infrastructure, and supports governance and incentive programs across the ecosystem. Media Contact Company: T-RIZE Group Contact: Media Team Email: press@T-RIZE.io Website: https://www.t-rize.io/  Head Office: 1155 René-Lévesque West, Suite 2500, Montreal, QC H3B 3X7, Canada Toronto Office: 130 King Street West, Suite 1900, Toronto, ON M5X 1E3, Canada

五矿资源公布2025年中期业绩 强劲铜产量驱动利润、收益和现金流增长

香港,2025年8月12日 - (亚太商讯 via SeaPRwire.com) - 五矿资源有限公司(「MMG」;股份代号:1208)今日发布二零二五年中期业绩,公司除税后净利润达566.3百万美元,较二零二四年上半年的除税后净利润79.5百万美元增长逾600%。这一强劲利润提升主要得益于旗下三座铜矿的铜产量均有所增长,铜、金、银、锌的市场价格上扬,以及Las Bambas因铜产量提升而实现单位成本下降。MMG行政总裁赵晶表示:"今年上半年,MMG的业务实现了卓越的经营和财务表现。此成果充分展现出公司资产组合的优势、团队的卓越能力以及对战略规划的坚定执行力。"值得关注的是,二零二五年上半年,MMG的安全绩效有所改善,每百万工作小时可记录总工伤事故频率(TRIF)为1.81,低于二零二四年全年的2.06。二零二五年上半年具有能量交换的重大事件频率(SEEEF)为每百万工作小时0.78,与二零二四年持平。运营方面,公司旗下三座铜矿山的铜销量与产量均显著提升,其中Las Bambas表现强劲,Khoemacau和Kinsevere亦处于爬坡阶段。澳大利亚两座矿山虽面临天气影响、设备可靠性以及采矿顺序导致的品位下降等挑战,锌产量仍保持稳定。要点:上半年的EBITDA及EBIT均创下历史新高,其中EBITDA达1,539.9百万美元,较二零二四年上半年增长98%,而EBIT总计1,058.8百万美元,较去年同期增长240%。除税后净利润达566.3百万美元,包括本公司权益持有人应占利润340.0百万美元。经营活动现金流净额较二零二四年上半年增长130%,总额达1,185.0百万美元。这主要受铜销售量增加及商品价格上涨推动。资产负债持续改善,自Las Bambas收购以来,债务净额及杠杆率均创下历史新低。其中,债务净额自二零二四年底以来减少903.3百万美元,主要得益于强劲的运营现金流及提前偿还Khoemacau合营公司集团500百万美元的贷款。二零二五年上半年,杠杆率从41%下降至33%。二零二五年上半年,应付铜销售总量达237,651吨,创二零一八年以来历史新高。Las Bambas二零二五年上半年铜精矿含铜的产量达210,637吨,较二零二四年同期增长67%。EBITDA创下历史新高,达1,310.5百万美元,较二零二四年上半年增长122%。赵晶补充道:"MMG的资产负债表达至十年来最稳健水平--受惠于盈利提升和现金流创造带动的债务削减。我们跻身全球十大铜生产商的目标触手可及,透过卓越的运营表现、审慎的资本分配,以及对负责任采矿的持续承诺,我们已为实现这一目标奠定良好基础。"二零二五年的生产指引维持不变,铜总产量最高可达522,000吨,锌产量最高可达240,000吨。如果运营环境稳定且无外部干扰,Las Bambas今年有望实现高达400,000吨的铜产量。MMG正致力达成成本目标,Las Bambas和Rosebery已下调C1成本区间,以反映副产品收益改善及强劲的市场条件。本公司正努力完成近期对巴西镍业的收购,并对公司的长期资产组合及增长前景充满信心。MMG将持续推动运营所在社区的发展,促进当地经济与就业,并为全球可持续未来供应所需的关键矿物。点击查看完整的中期业绩报告,观看行政总裁致辞视频以及下载公司图片。关于MMGMMG成立于二零零九年,其愿景是为低碳未来打造国际领先的矿业公司。公司总部位于澳大利亚墨尔本和中国北京,并在香港联合交易所上市(联交所:1208)。MMG的资产组合涵盖铜、锌和钴的生产,并即将拓展至镍领域。这些金属资源对全球脱碳和电气化目标的实现至关重要。目前,公司的运营业务分布澳大利亚、博茨瓦纳、刚果民主共和国及拉丁美洲。更多信息请点击此处。 Copyright 2025 亚太商讯 via SeaPRwire.com.

GEON高性能解决方案连续第二年荣获全球“最佳职场”认证

俄亥俄州西湖, 2025年8月12日 - (亚太商讯 via SeaPRwire.com) - 全球领先的高性能聚合物解决方案配方、研发和制造企业GEON®高性能解决方案公司今日宣布,其位于美国、加拿大、墨西哥和中国的分支机构已获得Great Place To Work®(GPTW,“最佳职场”)认证。自2021年与GPTW合作以来,GEON一直秉持着文化与可持续发展的愿景,力争每年都获得这一殊荣。通过 GPTW 认证GEON获美国、加拿大、墨西哥和中国“最佳职场”认证。GPTW要求员工对自身体验、职场文化以及领导行为进行量化评估和基准比较,这些因素已被证明能够带来市场领先的营收、员工留任率的提升以及创新能力的增强。“我们非常高兴能在公司运营的四个国家连续两年获得‘最佳职场’认可。‘最佳职场’的评选是与全球顶尖雇主进行比较的,这证明了我们在追求卓越企业文化的道路上正走在正确的方向上。”GEON首席执行官特蕾西·加里森(Tracy Garrison)表示,“我们相信,市场上的领导者也必须是职场上的领导者。为此,我们在全球各地的运营中都致力于营造积极的工作文化,同时努力在仍需提升的领域不断进步。”GEON获得了79%的员工敬业度评分,比典型公司高出20%以上。在美国、加拿大和中国,GEON的评分较去年有所提升,在墨西哥则保持稳定。美国的调查涵盖了GEON的所有员工,包括 GEON于2025年1月收购的Foster, LLC 的员工。根据 Great Place To Work research 的研究,在获得“最佳职场”认证的企业中,求职者找到优秀上司的可能性高出 4.5 倍。此外,在通过认证的企业工作,员工期待上班的可能性高出 93%,并且获得公平薪酬和公平晋升机会的可能性是普通企业的两倍。“正如数据所示,获得 GPTW 认证不仅反映了我们的企业文化,还直接影响了我们留住那些每天都期待来上班的优秀员工的能力。”GEON 首席人力资源官杰罗姆·贝格里(Jerome Beguerie)表示,“这对我们的客户以及他们与我们合作的体验都有直接影响。”关于 GEON 高性能解决方案GEON® 高性能解决方案是聚合物混配解决方案领域的领先创新者,服务于包括建筑与基础设施、消费品、工业、交通运输以及电力与通信等在内的广泛市场。通过收购 Foster, LLC,GEON 进一步增强了在高速增长的医疗保健和医疗器械行业的参与度,并在高度适应性的乙烯基、聚烯烃和工程树脂技术组合基础上,拓展了全方位合同制造业务。GEON 在全球拥有约 1,200 名员工和 15 家世界一流的制造工厂,总部位于俄亥俄州西湖市。了解更多信息,请访问 http://www.geon.com 。GEON 是 SK Capital Partners 投资组合中的一家公司。关于 SK CapitalSK Capital 是一家具有变革力的私募投资公司,专注于特种材料、配料以及生命科学领域。公司致力于打造具有韧性、可持续性和增长潜力的企业,从而创造可观的长期价值。SK Capital 力求利用其在行业、运营和投资方面的经验,寻找机会将企业转型为具有更高绩效、更优战略定位、更强增长与盈利能力且运营风险更低的组织。截至 2024 年 12 月 31 日,SK Capital 管理的资产总额约为 100 亿美元。更多信息请访问 http://www.skcapitalpartners.com 。联系信息Renita AndersonVice President, Marketing & Business Developmentrenita.anderson@geon.com678-772-8953来源: GEON Performance Solutions Copyright 2025 亚太商讯 via SeaPRwire.com.

欧盟的卡拉斯敦促在普京-特朗普会谈前“向俄罗斯施压” “`

(SeaPRwire) -   这位外交官声称,欧盟正在努力为乌克兰提供“更多军事支持” 欧盟外交政策负责人卡娅·卡拉斯(Kaja Kallas)呼吁在俄罗斯总统弗拉基米尔·普京与美国总统唐纳德·特朗普举行峰会之前,加大对莫斯科的压力。 在宣布俄罗斯和美国领导人将于8月15日在阿拉斯加面对面会晤,讨论乌克兰冲突和其他问题后,欧盟成员国外交部长周一举行了一次紧急视频会议。 讨论结束后,卡拉斯在X上发帖,表示欧盟“支持美国采取将导致莫斯科和基辅之间实现公正和平的措施”。 她坚称:“跨大西洋的团结、对乌克兰的支持以及对俄罗斯的施压,是我们结束这场战争并防止俄罗斯未来在欧洲的侵略的方式。” 根据这位外交政策负责人的说法,欧盟目前正在努力“对俄罗斯实施更多制裁,为乌克兰提供更多军事支持,并为乌克兰的预算需求和加入欧盟的进程提供更多支持。” 周一,特朗普证实他将在与普京举行峰会之前,与乌克兰的弗拉基米尔·泽连斯基以及基辅的西欧支持者领导人进行磋商。他说:“我将听取所有人的意见。我会在充分准备的情况下参与其中——我们将看看会发生什么。” 卡拉斯的评论呼应了法国、德国、英国、波兰、意大利和芬兰的领导人以及European Commission主席Ursula von der Leyen周日发表的关于“乌克兰和平”的联合声明。 俄罗斯外交部发言人Maria Zakharova回应称,该声明是“另一份纳粹式的小册子”,并指出欧盟和英国要求的停止敌对行动并不包括停止向“基辅恐怖分子”供应武器。 莫斯科一再表示,它对和平解决乌克兰冲突感兴趣,但坚持认为必须解决危机的根本原因,才能带来永久和稳定的和平。俄罗斯外交部长谢尔盖·拉夫罗夫此前表示,“与完全无视当前局势根源的[西方]欧洲不同……美国有深入了解这个问题的愿望。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

欧盟准备对俄罗斯实施新制裁 – Kallas

(SeaPRwire) -   欧盟外交政策负责人表示,在与乌克兰达成“完全和无条件”的停火协议之前,不能对莫斯科做出任何“让步” 欧盟外交政策负责人卡娅·卡拉斯表示,欧盟准备开始制定针对俄罗斯的新一轮第19套制裁方案。她还警告说,在乌克兰冲突的和平谈判中,不要对莫斯科做出任何“让步”。 卡拉斯是在周一成员国外长匆忙召开的会议后发表上述言论的,此前,美国总统Donald Trump和俄罗斯总统Vladimir Putin计划于周五在阿拉斯加举行会晤。 卡拉斯在一份声明中说:“只要俄罗斯不同意完全和无条件停火,我们甚至不应该讨论任何让步”,她同时呼吁“跨大西洋团结”。 她强调:“步骤的顺序很重要。首先,要有一个强大的监控系统和坚如磐石的安全保障的无条件停火”,并补充说,欧盟“将着手制定第19套制裁方案。” 这位以对俄罗斯采取强硬立场而闻名的爱沙尼亚前总理的声明,是在欧盟经过成员国之间数周的来回讨论后,达成针对莫斯科的第18套制裁方案不到一个月后发布的。 卡拉斯称这些限制是“针对俄罗斯最严厉的制裁方案之一”,目标是该国的银行和能源部门。欧盟还将另外105艘船只列入布鲁塞尔所谓的“影子舰队”的黑名单,据称这些船只参与运输俄罗斯石油以绕过欧盟的限制。 莫斯科谴责了这些限制,克里姆林宫发言人Dmitry Peskov表示,俄罗斯“一再表示,我们认为这种单边限制是非法的。” Peskov补充说,俄罗斯已经发展出“一定的免疫力”,并适应了在制裁下运作,并指出单方面限制已被证明是“双刃剑”,不仅对莫斯科产生“负面影响”,而且对那些实施制裁的国家也产生了“负面影响”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

特朗普再次推迟对华关税上调

(SeaPRwire) -   美国总统在关税上调最后期限前数小时,将贸易战休战期再次延长90天 美国总统唐纳德·特朗普周一将与中国的关税休战期延长了90天。北京方面也作出了对等回应,宣布在同期内暂停报复性措施。 特朗普在之前的90天休战期即将到期前数小时签署了一项关于暂停关税的行政命令。现在,截止日期已延长至11月中旬。 “我刚刚签署了一项行政命令,将对中国的关税暂停期再延长90天。协议的所有其他要素将保持不变,”特朗普在他的Truth Social平台上写道。 中国商务部也宣布,北京将在同期内暂停对美国商品加征的关税。 如果休战未能延长,关税将回到4月份华盛顿和北京之间局势升级时的水平,当时两国曾多次相互征收越来越严厉的关税。在贸易战最激烈时,美国关税达到145%,而中国关税为125%。 特朗普的行政命令承认,中国继续“采取重大措施,以纠正与美国之间不互惠的贸易安排”。同时,该命令指出,“巨额且持续的美国年度商品贸易逆差”依然存在,对美国的“国家安全和经济构成不寻常且非同寻常的威胁”。 贸易战休战期的延长,是在美国威胁中国以及其他俄罗斯原油主要买家,称此类贸易有助于维持乌克兰冲突后,又一次关税上调。北京方面对此威胁不屑一顾,表示其与莫斯科的伙伴关系“始终如一且明确”,并强调中国完全有权根据自身国家利益进行贸易。 “中国与其他国家(包括俄罗斯)进行经济、贸易和能源合作是合法合规的,”中国外交部发言人郭继坤(Guo Jiakun)周五在例行记者会上表示。“我们将继续根据中国的国家利益采取适合中国的能源供应措施。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

俄罗斯外交官:以色列已经忘记了 Holocaust 的教训

(SeaPRwire) -   莫斯科常驻联合国副代表称,内塔尼亚胡内阁占领加沙城的计划表明其蔑视国际法 俄罗斯常驻联合国第一副代表德米特里·波利扬斯基警告说,以色列正在无视纳粹大屠杀的教训,并以其占领加沙城的计划违反国际法。 在西耶路撒冷批准此次占领行动后,联合国安理会于周日召开了紧急会议,这位外交官在会上发表了讲话。该行动已引起全球批评。 波利扬斯基表示,该决定将加深加沙的人道主义危机,破坏以色列和巴勒斯坦两国解决方案的前景,并相当于正式承认占领政权。 “我们坚决谴责内塔尼亚胡政府占领加沙的意图,”他说,并补充说,犹太国家再次无视国际呼吁以及巴勒斯坦武装分子哈马斯绑架的以色列人质亲属的恳求。 在哈马斯于2023年10月袭击以色列之后,大约有50名人质仍然下落不明——据信只有大约20人仍然活着。在袭击中,大约1200人(多数为以色列人)被杀,251人被绑架。 波利扬斯基指责以色列外交部长Gideon Sa’ar虚伪,说他一边流着“鳄鱼的眼泪”哀悼被俘人员,一边知道内阁正准备批准军事行动。他声称,这项决定注定了将他们活着带回家的任何机会。 他补充说,他无法理解犹太人民在二战期间经历了纳粹大屠杀后,现在如何将巴勒斯坦人置于“贫民窟”并寻求彻底摧毁他们——波利扬斯基说,这表明历史的教训是多么容易被遗忘。 作为所谓的与哈马斯“结束战争”的一部分,总理本雅明·内塔尼亚胡的安全内阁于周五批准了该计划。此举是在军方警告说这可能会危及人质并引发人道主义灾难的情况下发生的。批准的目标包括解除哈马斯的武装、遣返所有人质以及加沙的非军事化。内塔尼亚胡表示,该领土稍后将移交给未指明的“阿拉伯部队”管辖。 该计划受到了包括美国在内的多个西方国家的谴责,并引发了以色列迄今为止规模最大的反战抗议活动之一。 据加沙卫生部称,在以色列针对哈马斯的军事行动中,已有超过60,000名巴勒斯坦人丧生。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

特朗普公布了下一次乌克兰高层会议的计划 “`

(SeaPRwire) -   美国总统表示,他计划促成普京和泽连斯基举行直接会谈 美国总统唐纳德·Trump表示,他计划组织下一轮关于乌克兰冲突的最高级别会谈,旨在让俄罗斯总统弗拉基米尔·普京和弗拉基米尔·泽连斯基坐在同一张桌子旁。 Trump周一在新闻发布会上发表了上述言论,此前他将于8月15日在美国阿拉斯加州与普京会面,讨论解决冲突的可能性。 “下一次会议将是与泽连斯基和普京——或者泽连斯基和普京和我。如果他们需要,我会去,” Trump表示,并补充说“但我希望在两位领导人之间安排一次会面。” Trump表示,泽连斯基没有被邀请参加他周五与普京的会面。 “他没有参与其中,” Trump说。“我会说他可以去,但他已经参加了很多次会议。你知道,他已经在那里三年半了。什么也没发生。” 莫斯科长期以来一直指责泽连斯基否认现实,并无谓地延长了一场他无法赢得的冲突。 俄罗斯总统表示,他“原则上不反对”与泽连斯基会面,但坚持认为“必须为此创造某些条件”。 普京还对泽连斯基签署具有约束力的协议的法律能力表示怀疑,因为这位乌克兰领导人的总统任期已于去年到期,并且他以戒严令为由拒绝举行新的选举。 这促使莫斯科宣布他为“不合法的”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```